The Principals and Consultants of Neurotoxicants.com are available to provide expert consultations in the following areas:
Government: Public Health and Worker Compensation
Note: The services offered herein by Dr. Ratner, D.B.A. Neurotoxicants.com are not part of her responsibilities at the Boston University Chobanian & Avedisian School of Medicine, but rather, this expertise is provided by her as a private consultant. Dr. Ratner will not accept payment from any external influences which could affect the objectivity of the editorial content of the Neurotoxicants.com website.
Last update: June 7, 2023.
Government: Public Health and Worker Compensation
- Dr. Ratner has completed Federal Emergency Management Agency (FEMA) Introduction to Hazardous Materials and Radiological Emergency Management training. She has also completed Incident Command System ICS-100 training and is available to assist Local Emergency Planning Committees (LEPCs) with the development of their Local Emergency Response Plans (these services are offered on a volunteer basis to all Local, State and Federal agencies).
- Dr. Ratner is available to assist Local, State and Federal Environmental Health Teams with the process of assessing, identifying, and recommending solutions for environmental threats to human health in water, food, soil, waste, and air (indoor and outdoor) that occur during a disaster (these services are offered on a volunteer basis to all Local, State and Federal Agencies).
- Conducting literature reviews, and evaluating current and past scientific literature and government regulations
- Assist with neurotoxicity risk assessments for setting public health and worker compensation policies
- Assist with interpretation of preclinical data and allometric scaling to estimate dose response relationships in humans
- Provide affidavits, position statements, white papers, study reports, and testimony for legislative review
- Assist with neurotoxicity risk assessments and development of plans for risk management based on hierarchy of controls
- Assist with development of risk reduction programs
- Assist with internal review and evaluation of industrial hygiene practices
- Assist with internal review and evaluation of occupational exposure records
- Assist with design and implementation of methods to improve industrial hygiene
- Assist with design and implementation of industrial hygiene surveys
- Conducting literature reviews
- Project Management
- Project Management and guidance on preclinical GLPs based on part 58 of CFR Title 21. As a Diplomate of the American Board of Toxicology, with training in preclinical pharmacology and drug discovery, Dr. Ratner has the appropriate education, training, and experience to serve as a study director on your project per the requirements stipulated under part 58 of CFR Title 21.
- Assist with preclinical drug discovery and product development processes
- Assist with Preclinical Safety Pharmacology/Toxicology study design for FDA Investigational New Drug (IND) Applications
- Assist with FDA Common Technical Document (CTD) M4S safety section preparation
- Advise on the implementation and interpretation of Preclinical Neurobehavioral Testing & Analytical methods including:
- Functional Observation Batteries
- Locomotor Activity Assessment
- Motor Coordination/Gait Analysis
- Learning and Memory Function
- Anxiety and Emotionality
- Design, set up, analysis and interpretation of in vivo electrophysiological studies of neural network actvity
- Selection of antibodies for analysis of biological markers indicative of interactions between drugs and age-related neurodegenerative disease processes
- Assist with design and implementation of early human clinical trials for drug safety
- Medical record reviews for neurotoxic tort, worker's compensation and medical malpractice claims
- Review and evaluate pertinent medical and scientific literature for paralegal purposes
- Provide expert support for patent litigation
- Provide expert testimony
- Assist with design and implementation of retrospective case-control and prospective cohort studies of neurotoxicity
- Assist with interpretation of exposure history and neurotoxicity data
- Assist with development of inclusion/exclusion criteria for study subject selection
- Project Management
Note: The services offered herein by Dr. Ratner, D.B.A. Neurotoxicants.com are not part of her responsibilities at the Boston University Chobanian & Avedisian School of Medicine, but rather, this expertise is provided by her as a private consultant. Dr. Ratner will not accept payment from any external influences which could affect the objectivity of the editorial content of the Neurotoxicants.com website.
Last update: June 7, 2023.
